NMRA Neumora Therapeutics, Inc.
Company Analysis
Latest News
🟢 Neumora Therapeutics is trading 7% up in pre-market as the reason remains unclear
Neumora Therapeutics is trading at $0.47, up 6.91%, with no confirmed explanation for its pre-market rise. - No confirmed company announcement explaining the...
🔴 Neumora Therapeutics is trading 5% down with no clear catalyst identified
Neumora Therapeutics is trading 5.02% lower at $0.45, with no confirmed catalyst identified. - No fresh company-specific announcement explaining the October...
🟢 Neumora Therapeutics is trading 5% up in pre-market
Neumora Therapeutics is trading 5% up at $0.50 in pre-market, but the reason for the increase remains unclear. - No fresh company-specific announcement...
🟢 Neumora Therapeutics rises 5.6% — Biotech Sector Rallies on Strong IPO Debuts and M&A Activity
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector is experiencing a significant rally,...
🟢 Neumora Therapeutics is trading 11% up in pre-market
Neumora Therapeutics is trading 11.04% higher at $0.52 before the October 8, 2026 open, with no verified company-specific catalyst identified. - Shares closed...
🔴 Neumora Therapeutics is trading 7.6% down in pre-market with no verified catalyst identified
Neumora Therapeutics is trading at $0.43, down 7.64% in October 7 pre-market; no verified company-specific announcement explains the move. - Shares closed at...
🟢 Neumora Therapeutics is trading 5% up in after-hours trading
Neumora Therapeutics is trading 5.1% up at $0.49 after-hours on October 6, with no verified company-specific announcement identified to explain the move. -...
🔴 Neumora Therapeutics is trading 10.32% down today amid possible biotech-sector pressure
Neumora Therapeutics is trading at $0.47, with a -10.32% move, as biotech-sector weakness may be contributing to the October 6 decline; no verified...
🔴 Neumora Therapeutics is trading 6.7% down
Neumora Therapeutics is trading at $0.49, down 6.70%, with no verified company-specific announcement or catalyst explaining the decline on October 6, 2026. -...
🟢 Neumora Therapeutics is trading 5% up amid broader market gains
Neumora Therapeutics is trading at $0.53, up 5.08%, on October 5, 2026; no clear company-specific announcement was found, while positive broader-market...
🔴 Neumora Therapeutics is trading 5.6% down
Neumora Therapeutics is trading at $0.47, down 5.64%, with no clear company-specific news identified to explain the October 5, 2026 decline. - The...
🟢 Neumora Therapeutics is trading 11.6% up in pre-market — despite no clear company-specific catalyst
Neumora Therapeutics is trading $0.56, up 11.62% versus the October 2 close of $0.50, after several steep declines over prior sessions. - No clear...
🔴 Neumora Therapeutics is trading 10.3% down — no clear company-specific catalyst identified
Neumora Therapeutics is trading 10.3% lower at $0.49; no clear company-specific catalyst has been identified for October 2, 2026. - Investor relations lists...
🔴 Neumora Therapeutics is trading 6% down with no clear catalyst identified
Neumora Therapeutics is trading 5.95% down at $0.52, with no clear company-specific catalyst identified for October 2. - The company’s investor-relations page...
🟢 Neumora Therapeutics is trading 6% up in after-hours trading with no clear catalyst identified
Neumora Therapeutics is trading 6.02% up at $0.58 after hours on October 1, 2026, reversing its regular-session decline, with no new company-specific...
🔴 Neumora Therapeutics is trading 5.2% down with no clear catalyst identified
Neumora Therapeutics is trading 5.2% down now at $0.56 on October 1, 2026, with no clearly identified company-specific catalyst. - No new company-specific...
🔴 Neumora Therapeutics is trading 11.2% down with no clear catalyst identified
Neumora Therapeutics is trading 11.2% lower at $0.60, with no verified company-specific catalyst identified. - No new company announcement or clearly linked...
🔴 Neumora Therapeutics is trading 5% down
Neumora Therapeutics is trading 5.03% down at $0.64 on September 30, 2026, with no new company announcement or clearly linked catalyst for the decline surfaced...
🔴 Neumora Therapeutics is trading 5.7% down — reason remains unclear
Neumora Therapeutics is trading 5.7% down at $0.65; the reason for the September 29, 2026 decline remains unclear. - The investor-relations page lists August...
🟢 Neumora Therapeutics is trading 7% up in pre-market
Neumora Therapeutics is trading at $0.74, up 6.98%, with no clear company-specific catalyst identified for the September 29 move. - The latest listed company...